Evidence map›Paper›PMID 28835904›Full record

ArticleBio-protocol2017

Expression and Purification of the Cas10-Csm Complex from Staphylococci.

Lucy Chou-Zheng, Asma Hatoum-Aslan

Open access · greenAbstract read
In one paragraph

Article in Bio-protocol, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lucy Chou-ZhengDepartment of Biological Sciences, University of Alabama, Tuscaloosa, AL, USA.
Asma Hatoum-AslanDepartment of Biological Sciences, University of Alabama, Tuscaloosa, AL, USA.
University of Alabama · US

Funding

Understanding CRISPR-cas regulation and its impact in staphylococciK22AI113106 · NIAID · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI HATOUM, ASMA · 2015 to 2016
$267k
NIAID NIH HHS K22 AI113106
6 · The paper itself

Abstract

CRISPR-Cas (Clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins) is a class of prokaryotic immune systems that degrade foreign nucleic acids in a sequence-specific manner. These systems rely upon ribonucleoprotein complexes composed of Cas nucleases and small CRISPR RNAs (crRNAs).

Indexed as

Biotin pull-downCas10-CsmCRISPR-Cas Type III-ADNA affinity chromatographyProtein ExpressionProtein purificationStaphylococci

Identifiers

PMID28835904
PMCPMC5564685
OpenAlexW2623769489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.